Vivanza Biosciences P/E Ratio
Vivanza Biosciences (VIVANZA) P/E ratio is not applicable — EPS (TTM) ₹0.10, 1 consecutive loss quarter. See Healthcare peers with valid P/E ratios below.
P/E Ratio Status
N/A
Loss Making
Company is currently reporting losses
P/E Ratio Not Applicable
Company reported a loss in the most recent quarter. P/E ratio is not meaningful for loss-making periods.
Consecutive Loss Quarters: 1
Current EPS: ₹0.10
Recent Quarterly Performance
| Quarter | EPS (₹) | Net Profit (₹ Cr) | Status |
|---|---|---|---|
| Mar 2026 | -0.11 | 0 | Loss |
| Sept 2025 | 0.14 | 1 | Profit |
| Mar 2025 | -0.25 | -1 | Loss |
| Jun 2025 | 0.02 | 0 | Profit |
| Dec 2025 | 0.05 | 0 | Profit |
| Mar 2024 | -0.10 | 0 | Loss |
| Jun 2024 | 0.07 | 0 | Profit |
| Dec 2024 | 0.01 | 0 | Profit |
Healthcare Peers with Valid P/E Ratios — VIVANZA Comparison
Healthcare sector average P/E 55.75, median 31.4 — VIVANZA excluded (negative EPS).
Sector Average PE
55.75
Sector Median PE
31.4
Lowest PE
2.86
Profitable Companies
194
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.61 | ₹64 | Low |
| Sunrest Lifescience | SUNREST | 3.82 | ₹31 | Low |
| Shelter Pharma | SHELTER | 4.69 | ₹43 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.76 | ₹7,399 | Low |
| JFL Life Sciences | JFLLIFE | 5.46 | ₹72 | Low |
| Dipna Pharmachem | DPL | 5.78 | ₹15 | Low |
| Mono Pharmacare | MONOPHARMA | 5.82 | ₹18 | Low |
| Amwill Health Care | AMWILL | 7.15 | ₹82 | Low |
| Zenith Drugs | ZENITHDRUG | 7.69 | ₹90 | Low |
Related Analysis
- For live price, revenue and the complete fundamental profile, see VIVANZA screener.
- Read VIVANZA dividend yield for the complete payout history and dividend yield track record.
- See Vivanza Biosciences P/B valuation to compare market price against book value per share.